68 related articles for article (PubMed ID: 33590401)
21. Efficacy of X-ray stereotactic radiotherapy on brain metastases and prognostic analysis.
Wei W; Deng ML; Wu SX; Zeng ZF; Li FY; Wang HY; Bao Y; Gao YH; Chen LX
Chin J Cancer; 2010 Feb; 29(2):202-6. PubMed ID: 20109352
[TBL] [Abstract][Full Text] [Related]
22. Changes in the characteristics of patients treated for brain metastases with repeat stereotactic radiotherapy (SRT): a retrospective study of 184 patients.
Kuntz L; Le Fèvre C; Jarnet D; Keller A; Meyer P; Thiery A; Cebula H; Noel G; Antoni D
Radiat Oncol; 2023 Jan; 18(1):21. PubMed ID: 36717863
[TBL] [Abstract][Full Text] [Related]
23. Immune checkpoint inhibition in patients treated with stereotactic radiation for brain metastases.
Kowalski ES; Remick JS; Sun K; Alexander GS; Khairnar R; Morse E; Cherng HR; Berg LJ; Poirier Y; Lamichhane N; Becker S; Chen S; Molitoris JK; Kwok Y; Regine WF; Mishra MV
Radiat Oncol; 2020 Oct; 15(1):245. PubMed ID: 33109224
[TBL] [Abstract][Full Text] [Related]
24. Validation of Nine Different Prognostic Grading Indexes for Radiosurgery of Brain Metastases in Breast Cancer Patients and Development of an All-Encompassing Prognostic Tool.
Weykamp F; El Shafie RA; König L; Seidensaal K; Forster T; Arians N; Regnery S; Hoegen P; Deutsch TM; Schneeweiss A; Debus J; Hörner-Rieber J
Front Oncol; 2020; 10():1557. PubMed ID: 33014802
[No Abstract] [Full Text] [Related]
25. Association of Sex, Age, and Eastern Cooperative Oncology Group Performance Status With Survival Benefit of Cancer Immunotherapy in Randomized Clinical Trials: A Systematic Review and Meta-analysis.
Yang F; Markovic SN; Molina JR; Halfdanarson TR; Pagliaro LC; Chintakuntlawar AV; Li R; Wei J; Wang L; Liu B; Nowakowski GS; Wang ML; Wang Y
JAMA Netw Open; 2020 Aug; 3(8):e2012534. PubMed ID: 32766800
[TBL] [Abstract][Full Text] [Related]
26. The combination of stereotactic radiosurgery with immune checkpoint inhibition or targeted therapy in melanoma patients with brain metastases: a retrospective study.
Martins F; Schiappacasse L; Levivier M; Tuleasca C; Cuendet MA; Aedo-Lopez V; Gautron Moura B; Homicsko K; Bettini A; Berthod G; Gérard CL; Wicky A; Bourhis J; Michielin O
J Neurooncol; 2020 Jan; 146(1):181-193. PubMed ID: 31836957
[TBL] [Abstract][Full Text] [Related]
27. Analysis of Heterogeneity in Survival Benefit of Immunotherapy in Oncology According to Patient Demographics and Performance Status: A Systematic Review and Meta-Analysis of Overall Survival Data.
Butaney M; Satkunasivam R; Goldberg H; Freedland SJ; Patel SP; Hamid O; Pal SK; Klaassen Z; Wallis CJD
Am J Clin Oncol; 2020 Mar; 43(3):193-202. PubMed ID: 31809328
[TBL] [Abstract][Full Text] [Related]
28. Poor-Performance Status Assessment of Patients with Non-small Cell Lung Cancer Remains Vague and Blurred in the Immunotherapy Era.
Friedlaender A; Banna GL; Buffoni L; Addeo A
Curr Oncol Rep; 2019 Nov; 21(12):107. PubMed ID: 31768759
[TBL] [Abstract][Full Text] [Related]
29. How do clinicians rate patient's performance status using the ECOG performance scale? A mixed-methods exploration of variability in decision-making in oncology.
Datta SS; Ghosal N; Daruvala R; Chakraborty S; Shrimali RK; van Zanten C; Parry J; Agrawal S; Atreya S; Sinha S; Chatterjee S; Gollins S
Ecancermedicalscience; 2019; 13():913. PubMed ID: 31123496
[TBL] [Abstract][Full Text] [Related]
30. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Use of Stereotactic Radiosurgery in the Treatment of Adults With Metastatic Brain Tumors.
Graber JJ; Cobbs CS; Olson JJ
Neurosurgery; 2019 Mar; 84(3):E168-E170. PubMed ID: 30629225
[TBL] [Abstract][Full Text] [Related]
31. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Whole Brain Radiation Therapy in Adults With Newly Diagnosed Metastatic Brain Tumors.
Gaspar LE; Prabhu RS; Hdeib A; McCracken DJ; Lasker GF; McDermott MW; Kalkanis SN; Olson JJ
Neurosurgery; 2019 Mar; 84(3):E159-E162. PubMed ID: 30629211
[TBL] [Abstract][Full Text] [Related]
32. Brain metastases: epidemiology.
Ostrom QT; Wright CH; Barnholtz-Sloan JS
Handb Clin Neurol; 2018; 149():27-42. PubMed ID: 29307358
[TBL] [Abstract][Full Text] [Related]
33. Do patients with reduced or excellent performance status derive the same clinical benefit from novel systemic cancer therapies? A systematic review and meta-analysis.
Cheng S; Qureshi M; Pullenayegum E; Haynes A; Chan KK
ESMO Open; 2017; 2(4):e000225. PubMed ID: 29209535
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO).
Soffietti R; Abacioglu U; Baumert B; Combs SE; Kinhult S; Kros JM; Marosi C; Metellus P; Radbruch A; Villa Freixa SS; Brada M; Carapella CM; Preusser M; Le Rhun E; Rudà R; Tonn JC; Weber DC; Weller M
Neuro Oncol; 2017 Feb; 19(2):162-174. PubMed ID: 28391295
[TBL] [Abstract][Full Text] [Related]
35. Individualized early death and long-term survival prediction after stereotactic radiosurgery for brain metastases of non-small cell lung cancer: Two externally validated nomograms.
Zindler JD; Jochems A; Lagerwaard FJ; Beumer R; Troost EGC; Eekers DBP; Compter I; van der Toorn PP; Essers M; Oei B; Hurkmans CW; Bruynzeel AME; Bosmans G; Swinnen A; Leijenaar RTH; Lambin P
Radiother Oncol; 2017 May; 123(2):189-194. PubMed ID: 28237400
[TBL] [Abstract][Full Text] [Related]
36. Patients with Long-Term Control of Systemic Disease Are a Favorable Prognostic Group for Treatment of Brain Metastases with Stereotactic Radiosurgery Alone.
Ebner DK; Gorovets D; Rava P; Cielo D; Kinsella TJ; DiPetrillo TA; Hepel JT
World Neurosurg; 2017 Feb; 98():266-272. PubMed ID: 27838432
[TBL] [Abstract][Full Text] [Related]
37. In Regard to Kubicek et al.
Vargas A; Conill C
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):921-922. PubMed ID: 27788966
[No Abstract] [Full Text] [Related]
38. Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): An American Society for Radiation Oncology evidence-based guideline.
Tsao MN; Rades D; Wirth A; Lo SS; Danielson BL; Gaspar LE; Sperduto PW; Vogelbaum MA; Radawski JD; Wang JZ; Gillin MT; Mohideen N; Hahn CA; Chang EL
Pract Radiat Oncol; 2012; 2(3):210-225. PubMed ID: 25925626
[TBL] [Abstract][Full Text] [Related]
39. The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline.
Linskey ME; Andrews DW; Asher AL; Burri SH; Kondziolka D; Robinson PD; Ammirati M; Cobbs CS; Gaspar LE; Loeffler JS; McDermott M; Mehta MP; Mikkelsen T; Olson JJ; Paleologos NA; Patchell RA; Ryken TC; Kalkanis SN
J Neurooncol; 2010 Jan; 96(1):45-68. PubMed ID: 19960227
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients.
Sperduto PW; Chao ST; Sneed PK; Luo X; Suh J; Roberge D; Bhatt A; Jensen AW; Brown PD; Shih H; Kirkpatrick J; Schwer A; Gaspar LE; Fiveash JB; Chiang V; Knisely J; Sperduto CM; Mehta M
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):655-61. PubMed ID: 19942357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
